Supplemental Materials for Stein Gold et al. Efficacy and Safety of Apremilast in Patients with Mild to Moderate Plaque Psoriasis: Results of a Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial. J Am Acad Dermatol. 2021.

Name: Supplemental Materials for Stein Gold et al. Efficacy and Safety of Apremilast in Patients with Mild to Moderate Plaque Psoriasis: Results of a Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial. J Am Acad Dermatol. 2021.
Creator: Linda Stein Gold
Published: 2021-08-20T15:14:32.352Z
Keywords: Clinical Trial, Scalp, Psoriasis, Quality of Life, Pruritus

Stein Gold, Linda; Papp, Kim; Pariser, David; Green, Lawrence; Bhatia, Neal; Sofen, Howard; Albrecht, Lorne; Gooderham, Melinda; Chen, Mindy; Paris, Maria; Wang, Yao; Callis Duffin, Kristina

doi:10.17632/djj5s5nyxc.2

Supplemental Materials for Stein Gold et al. Efficacy and Safety of Apremilast in Patients with Mild to Moderate Plaque Psoriasis: Results of a Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial. J Am Acad Dermatol. 2021.

Published: 20 August 2021| Version 2 | DOI: 10.17632/djj5s5nyxc.2

Contributors:

Linda Stein Gold, Kim Papp, David Pariser, Lawrence Green, Neal Bhatia, Howard Sofen, Lorne Albrecht, Melinda Gooderham, Mindy Chen, Maria Paris, Yao Wang, Kristina Callis Duffin

Description

Mendeley Supplemental Figures and Table for Stein Gold et al. Efficacy and Safety of Apremilast in Patients with Mild to Moderate Plaque Psoriasis: Results of a Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial. J Am Acad Dermatol. 2021.

Supplemental Materials for Stein Gold et al. Efficacy and Safety of Apremilast in Patients with Mild to Moderate Plaque Psoriasis: Results of a Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial. J Am Acad Dermatol. 2021.

Description

Files

Categories

Licence